Clinical trial
Use of Rifaximin in Patients With Functional Dyspepsia: A Randomized Controlled Trial
NCT01643083 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Rifaximin in Patients With Functional Dyspepsia: A Randomized Controlled Trial
- Lead sponsor
- The University of Hong Kong
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- May 31, 2015
- Enrollment
- 95 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
functional dyspepsia